Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history now lists Revision: v3.6.0, replacing Revision: v3.5.5. This reflects an update to the page's revision history for this study record.SummaryDifference0.4%

- Check15 days agoChange DetectedThe record history now shows a new latest revision 'Revision: v3.5.5', superseding the previous 'Revision: v3.5.4'.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous v3.5.3. This reflects a minor update to the site’s interface/versioning shown on the page rather than changes to the study data.SummaryDifference0.1%

- Check58 days agoChange DetectedThe ClinicalTrials.gov page now displays a newer site revision/version number (v3.5.3 instead of v3.5.2) while the underlying record history content remains the same.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check94 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.